Thalassemia and Sickle Cell Society and Kamala Hospital Research Center to host Asian Thalassemia Conclave 2026

Hyderabad will host the Asian Thalassemia Conclave (ATC) on January 10–11, bringing together medical experts, policymakers, NGOs and patient groups from across Asia to deliberate on strategies to combat thalassemia, a preventable genetic blood disorder.

Hyderabad: Hyderabad is set to host the Asian Thalassemia Conclave (ATC) on January 10 and 11, bringing together doctors, public health experts, policymakers, researchers, non-governmental organisations and patient groups from across India and Asia to discuss a coordinated response to thalassemia, one of the country’s most serious yet preventable genetic blood disorders.

The two-day conclave is being organised by the Thalassemia and Sickle Cell Society (TSCS), Hyderabad, an organisation that has been engaged in thalassemia care, prevention and advocacy for over 27 years along with Kamala Hospital Research Center. Dr. Chandrakant Agrawal, President, TSCS, met the Health Minister Damodar Raja Narasimha to brief him of the objectives and significance of the conclave.

---

TSCS is the world’s largest non-governmental organisation working exclusively for thalassemia patients and currently provides comprehensive treatment and long-term support free of cost to more than 4,588 patients, many of whom depend on the organisation for regular blood transfusions and specialised medical care, the organisers said in a press release.